undamentalytics Newsletter
Sign in

Elutia Inc. (ELUT) stock

Add to watchlist

Add holding +

NASDAQ: ELUT Nasdaq Health Care Equipment Next results ~November 5, 2026

Elutia Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: data-quality checks not passed.

Price vs value

Under review: data-quality checks not passed. We'll show the comparison once resolved.

Elutia Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders7 buying, 0 selling16 purchases and 0 sales by directors and officers, last 12 monthsInsider trades
  • Funds18 adding, 10 cuttingOf 4 active managers that changed their stake, 4 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Elutia files

Where Elutia stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $12m, down 0.3% on a year earlier, a smaller fall than the 20.8% decline a quarter earlier. Free-cash-flow margin fell to -379.3% from -277.8% a year earlier. Operating margin widened to -214.9% from -261.0%. The diluted share count is up 16.0% on a year earlier, which dilutes existing holders. It passes 2 of our 2 financial-health checks.

Our model value for Elutia is under review, so past values are not shown until it is resolved.

Source: 10-Q filed August 14, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 5, 2026 (estimated)

Elutia Inc.'s trailing-twelve-month revenue fell 0.3% year on year, with a free-cash-flow margin of -379.3%.

Current signal Net margin expanding: TTM net margin reached 426.9%, up 602.0pp year over year.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Margins widening. Operating margin is up 46.1 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.0bn.

Things to watch

  • Revenue shrinking. Revenue fell 0.3% over the last 12 months.
  • Loss-making. Operating margin is -214.9%: costs exceed revenue.
  • Burning cash. Free cash flow was -379.3% of revenue over the last 12 months.
  • Heavy stock-based pay. Stock pay equals 33.3% of revenue: a real cost that cash-flow figures leave out.
  • Share dilution. Diluted shares rose 16.0% in a year.
  • Volatile shares. Over the past year the shares showed annualised volatility of 75% and a beta of 0.3 against the S&P 500.

Latest results: FY2026 Q2

Filed August 14, 2026
Earnings per share
-$0.17 against an average estimate of -$0.15: missed by 13.3%
Revenue
$2m, down 11.6% on a year earlier
Share reaction
+15.0% in the first session after the results on August 13, 2026, against +0.5% for the S&P 500
Next report
November 5, 2026

Elutia's figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-1.9%
  • 1 week+2.9%
  • 1 month+5.4%
  • This year+18.5%
  • 1 year-9.7%
  • 5 years-86.2%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$12.1M
Operating margin
-214.9%
Net margin
426.9%
EPS (TTM, diluted)
$1.14

Growth

Revenue growth
−0.3%
Change in growth rate
+20.4 pts
Share count change
+16.0%

Cash

Free cash flow (TTM)
-$46M
FCF margin
-379.3%
Stock pay % of revenue
33.3%

Earnings

Last results
August 13, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Deal
  2. Results
  3. Agreement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Elutia Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: data-quality checks not passed.

Valuation multiples over time Market data may be delayed

At fiscal year end 202020212022202320242025Now
Share price$13.63$6.30$4.25$2.16$3.74$0.69$0.82
Market value$39m$66m$59m$39m$109m$32m$37m
+ Net debt (− = net cash)−$9m−$4m$7m$8m$12m−$5m−$20m
Enterprise value$30m$62m$66m$47m$121m$27m$17m
Multiples
Price / sales 0.9x1.4x2.5x1.6x7.5x2.6x3.1x
Price / earnings —————0.6x0.7x
Price / free cash flow ———————
EV / EBITDA ———————

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

27 /100

Weak moat

How hard Elutia's competitive advantage looks for rivals to wear away, judged from 7 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Cash operating profit has been a median -29.4% of total assets over 6 years.

  • Pricing power 12 / 20

    Gross margin has been a median 47.7%, moving by 6.4 percentage points (standard deviation) across 7 years.

  • Durability 10 / 20

    Operating margin has been a median -131.5%; its worst year was -261.0%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 6 years, at a median -80.0% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 5, 2026, after the close. Analysts expect revenue of $1m for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current −$0.63 −172% $8m −39%
Next −$0.54 +14% $4m −43%

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +5.0% on 90 days ago. In the last 30 days, 0 analysts raised Elutia Inc.'s forecast and 1 cut it.

Consensus EPS forecast Elutia Inc., last 90 days
−$0.80 −$0.60 −$0.40 −$0.20 $0.00 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: −$0.60 Current fiscal year, 60 days ago: −$0.60 Current fiscal year, 30 days ago: −$0.63 Current fiscal year, 7 days ago: −$0.63 Current fiscal year, Now: −$0.63 −$0.63 Next fiscal year, 90 days ago: −$0.52 Next fiscal year, 60 days ago: −$0.52 Next fiscal year, 30 days ago: −$0.54 Next fiscal year, 7 days ago: −$0.54 Next fiscal year, Now: −$0.54 −$0.54

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago −$0.60−$0.52
60 days ago −$0.60−$0.52
30 days ago −$0.63−$0.54
7 days ago −$0.63−$0.54
Now −$0.63−$0.54

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 −$0.15 −$0.17 −13.3%
Mar 2026 −$0.15 −$0.17 −13.3%
Dec 2025 −$0.14 $1.48 +1157.1%
Sept 2025 −$0.15 −$0.09 +41.9%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 13, 2026

No numeric guidance in Elutia Inc.'s latest earnings release (filed August 13, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

1 analysts, Oct 2026
Buy1100%
Hold00%
Sell00%

Monthly trend

  1. Oct 202611
  2. Sep 202611
  3. Aug 202611

Counts of recommendations published by analysts covering Elutia Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
0.0%
of tradable shares
Days to cover
0.04
at average volume
Short interest, 1 month
+86%
to October 15, 2026
Held by institutions
44%
of shares
Held by insiders
3.6%
of shares
Employees
25
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

What moved the share price

Last 12 months −9.7%

$0.91 on October 31, 2025 to $0.82

ThenNowEffect
Revenue (last 12 months) $12m $12m −0.3%
P/S multiple 2.9x 3.1x +5.1%
Share count 39m 45m −13.8%

Biggest factor: share count. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
ELUT−54%−33%−49%+73%−82%+19%
Industry peers (median)−7%−37%−8%−20%−16%−15%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
ELUT25%42%50%50%50%46%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
ELUT−75%−60%−77%−45%−87%−40%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since October 8, 2020: 97% from February 3, 2021 to December 17, 2025. Getting back needed a 3150% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.51 – $1.22
From 52-week high
−32.7%
vs 50-day average
−1.0%
vs 200-day average
−15.7%
Volatility (1 year)
75%
Beta vs S&P 500
0.30

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
6 up, 6 down
typical move ±9.0%
After a week
8 up, 4 down
typical move ±12.7%
After a month
5 up, 7 down
typical move ±17.1%
Results releasedNext dayS&P 500 next day5 days21 days
August 13, 2026 +15.0% +0.5% +10.3% −4.0%
May 14, 2026 −1.9% −0.4% +14.3% −7.7%
March 11, 2026 +5.5% −1.6% −0.9% +3.7%
January 12, 2026 +21.2% 0.0% +16.5% +24.5%
November 6, 2025 −6.8% −1.0% −22.6% −29.4%
August 14, 2025 −6.5% −0.2% +1.9% −43.5%
May 8, 2025 +8.3% +0.6% −9.4% −1.6%
March 6, 2025 −1.2% −1.2% +15.7% −3.6%
February 3, 2025 −18.6% 0.0% −20.8% −12.7%
November 14, 2024 −5.1% −1.9% +17.3% +10.1%
August 7, 2024 +4.8% +1.6% +12.6% +45.4%
May 9, 2024 +12.7% +0.7% +10.3% +18.8%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Elutia Inc.
$10M $15M $20M $25M $30M FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $25.5M Revenue (TTM), FY23 Q4: $24.7M Revenue (TTM), FY24 Q1: $25M Revenue (TTM), FY24 Q2: $25M Revenue (TTM), FY24 Q3: $22.5M Revenue (TTM), FY24 Q4: $19.5M Revenue (TTM), FY25 Q1: $15.7M Revenue (TTM), FY25 Q2: $12.2M Revenue (TTM), FY25 Q3: $11.8M Revenue (TTM), FY25 Q4: $12.3M Revenue (TTM), FY26 Q1: $12.5M Revenue (TTM), FY26 Q2: $12.1M $12.1M

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $25.5M
FY23 Q4 $24.7M
FY24 Q1 $25M
FY24 Q2 $25M
FY24 Q3 $22.5M
FY24 Q4 $19.5M
FY25 Q1 $15.7M
FY25 Q2 $12.2M
FY25 Q3 $11.8M
FY25 Q4 $12.3M
FY26 Q1 $12.5M
FY26 Q2 $12.1M
Revenue growth, TTM YoY Elutia Inc.
-60% -40% -20% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -37.7% Revenue growth, TTM YoY, FY23 Q4: -32.3% Revenue growth, TTM YoY, FY24 Q1: -20.4% Revenue growth, TTM YoY, FY24 Q2: -0.8% Revenue growth, TTM YoY, FY24 Q3: -11.5% Revenue growth, TTM YoY, FY24 Q4: -21.3% Revenue growth, TTM YoY, FY25 Q1: -37.2% Revenue growth, TTM YoY, FY25 Q2: -51.3% Revenue growth, TTM YoY, FY25 Q3: -47.4% Revenue growth, TTM YoY, FY25 Q4: -36.8% Revenue growth, TTM YoY, FY26 Q1: -20.8% Revenue growth, TTM YoY, FY26 Q2: -0.3% -0.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -37.7%
FY23 Q4 -32.3%
FY24 Q1 -20.4%
FY24 Q2 -0.8%
FY24 Q3 -11.5%
FY24 Q4 -21.3%
FY25 Q1 -37.2%
FY25 Q2 -51.3%
FY25 Q3 -47.4%
FY25 Q4 -36.8%
FY26 Q1 -20.8%
FY26 Q2 -0.3%
Operating margin (TTM) Elutia Inc.
-300% -200% -100% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: -123.9% Operating margin (TTM), FY23 Q4: -123.4% Operating margin (TTM), FY24 Q1: -122.4% Operating margin (TTM), FY24 Q2: -131.5% Operating margin (TTM), FY24 Q3: -153.9% Operating margin (TTM), FY24 Q4: -172.7% Operating margin (TTM), FY25 Q1: -203.1% Operating margin (TTM), FY25 Q2: -261.0% Operating margin (TTM), FY25 Q3: -234.9% Operating margin (TTM), FY25 Q4: -218.9% Operating margin (TTM), FY26 Q1: -212.6% Operating margin (TTM), FY26 Q2: -214.9% -214.9%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 -123.9%
FY23 Q4 -123.4%
FY24 Q1 -122.4%
FY24 Q2 -131.5%
FY24 Q3 -153.9%
FY24 Q4 -172.7%
FY25 Q1 -203.1%
FY25 Q2 -261.0%
FY25 Q3 -234.9%
FY25 Q4 -218.9%
FY26 Q1 -212.6%
FY26 Q2 -214.9%
FCF margin (TTM) Elutia Inc.
-400% -300% -200% -100% 0% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -72.2% FCF margin (TTM), FY23 Q4: -89.3% FCF margin (TTM), FY24 Q1: -77.5% FCF margin (TTM), FY24 Q2: -85.1% FCF margin (TTM), FY24 Q3: -89.1% FCF margin (TTM), FY24 Q4: -119.8% FCF margin (TTM), FY25 Q1: -189.7% FCF margin (TTM), FY25 Q2: -277.8% FCF margin (TTM), FY25 Q3: -281.9% FCF margin (TTM), FY25 Q4: -379.8% FCF margin (TTM), FY26 Q1: -367.9% FCF margin (TTM), FY26 Q2: -379.3% -379.3%

Source: SEC EDGAR filings. Retrieved October 29, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -72.2%
FY23 Q4 -89.3%
FY24 Q1 -77.5%
FY24 Q2 -85.1%
FY24 Q3 -89.1%
FY24 Q4 -119.8%
FY25 Q1 -189.7%
FY25 Q2 -277.8%
FY25 Q3 -281.9%
FY25 Q4 -379.8%
FY26 Q1 -367.9%
FY26 Q2 -379.3%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Jun 2026
Income
Revenue 43 43 47 24 25 14 12 12
Gross profit 20 21 19 12 11 7 7 7
EBITDA −5 −10 −19 −31 −27 −27 −24 −24
Operating income −8 −14 −23 −35 −31 −31 −27 −26
Net income −12 −22 −25 −33 −38 −54 53 52
Diluted EPS −$18.48 −$8.88 −$2.38 −$2.38 −$2.07 −$1.86 $0.87 $1.14
Growth (year on year)
Revenue — −0.5% +11.0% −49.7% +3.8% −41.5% −15.0% −0.3%
Margins
Gross margin 46.1% 48.2% 40.1% 48.8% 44.7% 46.4% 53.7% 57.8%
EBITDA margin −10.6% −22.8% −40.7% −131.9% −108.2% −188.4% −196.3% −200.8%
Operating margin −19.6% −31.9% −48.6% −147.5% −123.4% −212.3% −218.9% −214.9%
Net margin −27.8% −51.1% −52.4% −137.9% −152.2% −372.9% 434.2% 426.9%
Free-cash-flow margin −18.2% −33.4% −33.4% −92.1% −89.3% −161.1% −379.8% −379.3%
Cash flow
Cash from operations −7 −14 −15 −21 −22 −23 −45 −44
Capital spending 1 1 0 1 0 1 2 2
Free cash flow −8 −14 −16 −22 −22 −23 −47 −46
Stock-based pay 0 1 4 4 2 8 5 4
Free cash flow after stock pay −8 −15 −19 −26 −25 −31 −52 −50
Balance sheet
Cash 2 39 30 17 19 13 36 20
Total debt 26 31 27 24 27 25 31 —
Net debt (negative = net cash) 23 −9 −4 7 8 12 −5 −20
Diluted shares — 3m 10m 14m 18m 29m 46m 45m

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 2 checks passed · June 30, 2026
What it owns · $44m
Short-term assets $37mLonger-term assets $6m
What it owes, and who funded it · $44m
Short-term liabilities $21mLonger-term liabilities $7mShareholders' equity $16m
  • Short-term assets cover short-term liabilities $37m of assets due within a year against $21m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $37m short-term assets against $7m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Elutia Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Diluted share count
+16.0%
year over year
R&D spending
56.1%
of revenue
Days sales outstanding
43 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in health care equipment
Last 12 months unless stated ELUT HSDT NNOX NSPR WOK MDAI Median
Revenue, last 12 months $12m $12m $13m $11m $10m $15m $95m
Revenue growth, last 12 months −0.3% >999% 15.4% 53.4% −14.4% −44.1% 9.1%
Revenue growth, 3-year average −21.6% 142.6% — 26.6% — −11.8% 13.0%
Revenue growth, latest quarter −11.6% >999% — −0.4% — −30.4% 9.9%
Gross margin 57.8% 95.5% −98.2% 18.1% 23.8% 42.9% 61.1%
Operating margin −214.9% <−999% −600.8% −494.0% — −77.2% −8.7%
Operating margin, 3-year average −202.5% <−999% — −501.9% — −49.1% −17.9%
Net margin 426.9% <−999% −576.1% −484.1% −10.9% −65.5% −11.7%
Cash from operations / revenue −362.5% −223.2% −313.3% −380.1% 63.4% −83.7% −2.1%
Free-cash-flow margin −379.3% −223.2% −345.6% −391.7% 49.9% −84.4% −4.0%
Free-cash-flow margin, 3-year average −247.4% <−999% — −372.4% — −58.8% −7.7%
Stock pay / revenue 33.3% 69.3% 32.2% 98.8% — 10.0% 6.3%
Change in share count 16.0% >999% 10.4% 63.5% 128.1% 38.4% 4.0%

Median of all 135 companies we cover in health care equipment. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Women S Health $9.1M 74.3% ▼ 20.9%
Cardiovascular $3.2M 25.7% ▲ 8.3%

From Elutia Inc.'s 10-K filed March 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$17M
Institutions reporting
39
Shares held vs prior quarter
▲ 15.6%
Positions opened / closed
8 / 3

Top buyers and sellers, Q2 2026: 18 institutions bought and 10 sold ; the biggest buyer was Nantahala Capital Management, LLC (+3.2M shares) and the biggest seller Aigh Capital Management LLC (−900K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Nantahala Capital Management, LLC $6.2M 6.4M 36.8% ▲ 100.0%
Aigh Capital Management LLC $2.6M 2.7M 15.6% ▼ 25.0%
Knollwood Investment Advisory, LLC $2.5M 2.6M 14.8% 0.0%
Silverarc Capital Management, LLC $2.1M 2.2M 12.7% ▼ 12.2%
Vanguard Capital Management LLC $1.1M 1.1M 6.6% ▲ 11.6%
Perkins Capital Management Inc $379,934 694K 2.2% ▼ 8.3%
Geode Capital Management, LLC $279,437 285K 1.6% ▼ 2.8%
Corient Private Wealth LP $248,329 254K 1.5% ▲ 1.8%
Renaissance Technologies LLC $197,699 202K 1.2% ▲ 144.0%
Vanguard Fiduciary Trust Co $168,997 172K 1.0% ▲ 44.5%
Blackrock, Inc. $164,433 168K 1.0% ▲ 37.5%
Birchview Capital, LP $161,726 165K 1.0% 0.0%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Elutia Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $236,695 16 trades by 7 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $236,695 net buying
Insider Date Trade Shares Price Value
Neels Guido J Director January 30, 2026 Buy 20,000 $1.04 $20,800
Rakin Kevin Director January 30, 2026 Buy 70,000 $1.06 $74,200
Neels Guido J Director January 29, 2026 Buy 15,000 $1.06 $15,900
Neels Guido J Director January 28, 2026 Buy 15,000 $1.06 $15,900
Ferguson Matthew CHIEF FINANCIAL OFFICER December 17, 2025 Buy 60,000 $0.53 $31,800
Mills C Randal PRESIDENT AND CEO December 17, 2025 Buy 3,000 $0.51 $1,530
Makes Brigid Director December 17, 2025 Buy 25,000 $0.52 $13,000
Colpman David Director December 17, 2025 Buy 12,500 $0.51 $6,375
Highcape Partners Gp Ii, Llc 10% owner December 17, 2025 Buy 50,000 $0.52 $26,000
Ferguson Matthew CHIEF FINANCIAL OFFICER December 2, 2025 Buy 5,500 $0.67 $3,685
Ferguson Matthew CHIEF FINANCIAL OFFICER December 1, 2025 Buy 4,500 $0.65 $2,925
Mills C Randal PRESIDENT AND CEO November 24, 2025 Buy 5,000 $0.60 $3,000

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • August 13, 2026
  • May 14, 2026
  • March 11, 2026
  • January 12, 2026
  • November 6, 2025
  • August 14, 2025

Recent SEC filings

Data status

When each part of this page on Elutia Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Elutia Inc. in brief

What does Elutia Inc. do?
Elutia Inc. is a US-listed company in the health care equipment industry. Its financial year ends in December.
What is Elutia Inc.'s stock ticker?
Elutia Inc. trades under the ticker ELUT on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Elutia Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Elutia Inc. reported revenue of $12.1M, 0.3% lower than a year earlier, according to its SEC filings.
What is Elutia Inc.'s free cash flow?
Elutia Inc.'s free-cash-flow margin is -379.3% of revenue over the trailing twelve months.
Who are Elutia Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Nantahala Capital Management, LLC, Aigh Capital Management LLC and Knollwood Investment Advisory, LLC. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Elutia Inc.'s market cap?
On November 2, 2026, Elutia Inc.'s market capitalisation was about $37.3M, with a price-to-earnings ratio of 0.7 and net debt of -$19.9M. Market figures come from third-party market data and may be delayed.
Who are Elutia Inc.'s competitors?
In our Health Care Equipment peer group, the companies closest to Elutia Inc. are Solana Co, Nano-x Imaging Ltd., Inspiremd, Inc., Work Medical Technology Group LTD and Spectral AI, Inc. The side-by-side comparison below sets their revenue, margins and growth against Elutia Inc.'s.
Are insiders buying or selling Elutia Inc. stock?
Over the last 12 months, Elutia Inc.'s directors and officers reported 16 open-market purchases and 0 sales on Form 4. The insider trading page charts every trade.
When is Elutia Inc.'s next earnings date?
Around November 5, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Elutia Inc. announces its own schedule.